My Precision Oncology Program (MyPOP)

The Vancouver Prostate Centre's MyPOP (My Precision Oncology Program) is a recently launched clinical research program which strives to better deliver personalized therapeutics to patients with advanced or treatment-resistant cancer of the prostate, kidney or bladder.

The program is currently available only to patients of the VPC or BCCA who meet specific clinical trial criteria.

The program's objectives are to:

  • Develop standardized procedures to enable routine linking of genomic sequencing data with clinical decision making,
  • Integrate research and development of plasma DNA and RNA assays into clinical practice, and
  • Integrate clinical information with novel model systems

A schematic overview of the program is below:

MyPOP Schematic

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Conference Flyer Page 1

Breast & Prostate Cancer half-day virtual conference: Saturday, September 18th, 2021

The What you Need to Know for Your Patients Post Breast & Prostate Cancer Conference, taking place online on Saturday, September 18th, 2021 from 8:00am – 1:30pm, is an accredited virtual half-day conference focusing on screening, treatment, side-effect management & emerging new therapies for breast & prostate cancer patients. Click here for more information and to register. 

Dr. Peter Black, team captain

Terry Fox Run fundraiser: September 19th, 2021

The 41st Annual Terry Fox Run is taking place on Sunday September 19, 2021. If you are able, please consider donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research. 

Employment

Work at the Vancouver Prostate Centre

Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer

Tuesday, August 3, 2021

Dr. Cherkasov receives 2021 Faculty of Medicine Distinguished Achievement Award

Dr. Cherkasov